Is Your Oncology Sales Pipeline at Risk? How to Capitalize on the Patent Cliff Before It’s Too Late
In the high-stakes world of oncology, innovation isn’t just a competitive advantage—it’s a survival strategy. Yet, as many pharmaceutical companies appr…
In the high-stakes world of biopharmaceutical innovation, timing isn’t just everything—it’s the difference between leading the market and playing catch-up. As the patent cliff approaches for blockbuster biologics, a new frontier emerges: biosimilars. B…
In the high-stakes world of pharmaceuticals, the phrase “proving sameness” has never carried more weight—or more controversy. As the global healthcare industry grapples with soaring drug prices and the urgent need for affordable medicines, a seismic sh…
Prove It’s the Same: The $200 Billion Bioequivalence Fight Reshaping Generic Drugs Read Post »
In the relentless race to bring life-saving drugs to market, the path from discovery to approval is often fraught with delays, hefty costs, and unpredictable hurdles. But what if there was a smarter, more efficient route—one that could streamline devel…
In the high-stakes world of pharmaceutical innovation, the recent passage of the Inflation Reduction Act (IRA) has sent shockwaves through industry corridors and policy halls alike. But beyond the headlines and political debates lies a complex reshapin…
The IRA Price Reset: What It Actually Does to Pharma Pricing, and What Comes Next Read Post »
The Patent Wall Is Crumbling: How Secondary Abandonment Is Reshaping the Future of Drug Innovation
In the high-stakes world of pharmaceuticals, patent protection has long been the fortress guarding billions in revenue and the promise of innovation. But…
When the Patent Wall Crumbles: Secondary Abandonment and the Death of Drug Evergreening Read Post »
In the fiercely competitive world of pharmaceuticals, innovation alone isn’t enough. Success hinges on strategic foresight—knowing when and how to secure the right patent licenses to unlock market potential and maximize ROI. Yet, many companies stumble…
The Strategic Playbook for Identifying and Securing Drug Patent Licensing Opportunities Read Post »
In the relentless race to develop groundbreaking new medicines, the pharmaceutical industry often overlooks a powerful, underutilized strategy: drug repurposing. As highlighted in a compelling recent article on Drug Patent Watch, "No Patents, No P…
No Patents, No Problem: The Untapped Power of Drug Repurposing Read Post »
Unlocking the Hidden Barriers to Generic Drug Entry: Beyond the API Patent
In the high-stakes world of pharmaceuticals, the race to bring affordable generics to market is often viewed through the lens of primary patents—those obvious, blockbuster prote…
Beyond the API: Mapping the Secondary Patent Thicket to Forecast Generic Entry Read Post »
In the fiercely competitive world of specialty pharmacy, margins are razor-thin, and every percentage point counts. But what if there was a strategic move that could potentially double your margins overnight? Sound too good to be true? Think again.
The…
Double Your Specialty Pharmacy Margins the Day Generics Launch Read Post »
Get new actionable insights and updates from BiotechBlog
